LILRB2 Antibody Blocking Peptide
This product is LILRB2 Antibody Blocking Peptide. It targets Leukocyte immunoglobulin-like receptor subfamily B member 2. Purification is performed using HPLC.
Product Specifications
Product Name Alternative
CD85D; CD85 antigen-like family member D; CD85d; CD85d antigen; ILT 4; ILT-4; ILT4; Immunoglobulin like transcript 4; Immunoglobulin-like transcript 4; Leukocyte immunoglobulin like receptor 2; Leukocyte immunoglobulin like receptor subfamily B member 2; Leukocyte immunoglobulin-like receptor 2; Leukocyte immunoglobulin-like receptor subfamily B member 2; Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2; LILRA6; LILRB2; LIR 2; LIR-2; LIR2; LIRb; LIRB2_HUMAN; MIR 10; MIR-10; MIR10; Monocyte/macrophage immunoglobulin like receptor 10; Monocyte/macrophage immunoglobulin-like receptor 10.
Field of Research
Immunology & Inflammation
Storage Conditions
Shipped at 4°C. Stored at -20°C for one year. Avoid repeated freeze/thaw cycles.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15366094 1 Vial
Lentiviral human TACR3 sgRNA gene knockout kit - Lentiviral human TACR3 sgRNA gene knockout kit (100)
Sign In for Pricing
View Details 
